Medical College of Georgia 145 CMC Home A-Z Index MCG Home
Home
Faculty
Education
Links
Residency
Residents
Alumni
Giving
City/Campus
Login

Back to Alumni Page

The 44th Graduating Class...

Rebecca Bobo, M.D.

David Eifrig, Jr. M.D.

McGregor Lott, M.D.
- Chief Resident -

Date:  June 22nd and 23rd, 2007.

Commencement was held together with the 31st Annual Resident-Alumni Meeting at the The Ritz-Carlton Lodge of Reynolds Plantation at Lake Oconee, Georgia. This was the second time we met at this venue.  This year the techs and staff were invited. Most of the department was present for the meeting.

Commencement & Roast.

One of the highlights of this years meeting was the surprise arrival of Dr. Parag Gokhale from Seattle.  Dr. Gokhale moved to Seattle in the summer of 2006 and since he had known this class for 2 years he wanted to be a part of their graduation. The question was how to arrange it.  Well, he, Dr. Ulrich and Jenny Roberts coordinated a surprise arrival.  Dr. Gokhale had 4 video's sent to Dr. Ulrich the first being a pre-recorded monologue on Dr. Gokhale's part where he pretended to be connecting via satellite link. The other video's were his arrival by Dr. Evil's Time Machine from Austin Powers.  Fireworks over the Space Needle in Seattle with "thunderous applause" were playing on the screen when he walked out waving amicably as hero of the weekend.  It went over very well and to no small excitement on the part of the seniors.  Dr. Gokhale then moderated then a.m. resident paper session in which all three seniors and Dr. Nilson (a second year resident who had done considerable research with Dr. Gokhale) presented. 

Dr. Nussbaum began the commencement activities with has admonishments to the departing seniors.  Dr. Ambati followed with his "Superhero" roast of the residents which transitioned into Dr. Gokhale's (presumably final...but who knows...) "Before they were stars!" talk. In this talk he predicts a fictitious ophthalmic future after these seniors make their contributions.  According to the predictions Dr. Bobo is to rise in politics with her good heart but strong ideas and powers of persuasion.  Dr. Eifrig is to become a rich, but generous philanthropist who owns a fleet of ships. Dr. Lott is to become a master surgeon who incorporates nanotechnology into his eye care.  

In a Gilligan's Island / ABC's Lost parody the three of these docs get get mixed up on an island trying to solve a problem with local quail eyes.  One of Dr. Eifrig's ships with he and Dr. Lott aboard will get stranded on quail island where it will be up to Dr. Lott to use nanotech to fix the problems. Eventually, it will take Dr. Bobo's (by then the governor of Florida) negotiation skills to secure the release of these other two docs from captivity on quail island. [It's a stretch, but good for a laugh and a memory.]

Dr. Bobo will enter private practice in Florida.  Dr. Eifrig is pursuing private practice / research, and Dr. Lott will be doing a medical retina fellowship at Bascom Palmer Eye Institute.

Academic Activities:

On Friday Dr. Lane Ulrich opened the program and we heard from all nine residents as they presented the research they have been participating in during the last year. The talks ranged from the retina (new cell population, neovascularization), the optic nerve (exercise induced changes and drop compliance), to corneal angiogenesis, room temperature graft preservation, resident cataract surgery and a rousing video capture talk. Below are the talks which were presented by these three graduating seniors. 

Dr. Jeff Odel presented case studies in neuro-ophthalmology as well as how to  distinguish between maculopathy and optic neuropathy.  Dr. Olson presented work on phacoemulsifier's, endophthalmitis and an introduction to chelation therapy and its effect on cataracts.

Rebecca Bobo, M.D.

“Clinical Outcomes of Resident Cataract Surgery with Vitreous Loss”

David Eifrig, Jr., M.D.

“Exercise Induced Changes in the Normal Optic Nerve.”

McGregor Lott, M.D.

“Treatment of Polypoidal Choroidal Vasculopathy with Ranibizumab: A Phase I/II safety study.”

Top of Page


         Copyright 2007
Medical College of Georgia
     All rights reserved.

Please email comments, suggestions or questions to web manager

 

June 27, 2007